(FLO) Flowers Foods - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3434981011
FLO EPS (Earnings per Share)
FLO Revenue
FLO: Fresh Breads, Buns, Rolls, Snacks, Frozen
Flowers Foods, Inc. is a leading producer and marketer of packaged bakery products in the United States, operating under several well-known brand names including Natures Own, Daves Killer Bread, and Wonder. The companys diverse product portfolio includes fresh and frozen breads, buns, rolls, and snack items, distributed through a combination of direct-store-delivery and warehouse delivery systems. With a long history dating back to 1919, Flowers Foods has established itself as a major player in the baked goods industry, serving a wide range of customers including retailers, foodservice providers, and institutions.
From a business perspective, Flowers Foods has demonstrated its ability to adapt to changing consumer preferences, leveraging its brand portfolio to drive growth in the packaged bakery market. The companys operational efficiency is supported by its network of bakeries and distribution systems, enabling it to maintain a strong presence in the market. With a market capitalization of $3.59 billion, Flowers Foods is a significant player in the packaged foods industry.
Analyzing the companys
From a fundamental perspective, Flowers Foods has a P/E ratio of 15.32, which is relatively reasonable compared to its industry peers. The companys RoE of 16.24% indicates a decent level of profitability. Considering the
Combining both technical and fundamental analysis, our forecast suggests that Flowers Foods is likely to experience a short-term price increase, potentially reaching $17.50, driven by the support level at $16.69. In the longer term, the companys stable financials and operational efficiency are expected to drive growth, potentially leading to a price target of $20.00 within the next 6-12 months.
Additional Sources for FLO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FLO Stock Overview
Market Cap in USD | 3,446m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception | 1987-11-05 |
FLO Stock Ratings
Growth Rating | -28.1 |
Fundamental | 48.0 |
Dividend Rating | 67.3 |
Rel. Strength | -33 |
Analysts | 3.13 of 5 |
Fair Price Momentum | 15.05 USD |
Fair Price DCF | 32.39 USD |
FLO Dividends
Dividend Yield 12m | 5.31% |
Yield on Cost 5y | 5.17% |
Annual Growth 5y | 3.76% |
Payout Consistency | 89.9% |
Payout Ratio | 76.8% |
FLO Growth Ratios
Growth Correlation 3m | -90.5% |
Growth Correlation 12m | -84.2% |
Growth Correlation 5y | 5.4% |
CAGR 5y | -3.11% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | -1.23 |
Alpha | -29.65 |
Beta | -0.077 |
Volatility | 22.51% |
Current Volume | 2561.6k |
Average Volume 20d | 3009.2k |
As of June 16, 2025, the stock is trading at USD 15.97 with a total of 2,561,552 shares traded.
Over the past week, the price has changed by -4.71%, over one month by -5.03%, over three months by -13.68% and over the past year by -25.98%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Flowers Foods (NYSE:FLO) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.95 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FLO is around 15.05 USD . This means that FLO is currently overvalued and has a potential downside of -5.76%.
Flowers Foods has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold FLO.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, FLO Flowers Foods will be worth about 16.3 in June 2026. The stock is currently trading at 15.97. This means that the stock has a potential upside of +1.75%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 18.6 | 16.3% |
Analysts Target Price | 18.6 | 16.3% |
ValueRay Target Price | 16.3 | 1.8% |